| Metric | შპს ფემილი ფარმ | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾5.0m₾3.9m | ₾2.11bn₾1.93bn |
| Revenue growth | 28.7% | 9.5% |
| Profitability | ||
| EBITDA | -₾7.3m-₾1.7m | — |
| EBITDA margin | -144.9%-42.6% | — |
| Net profit | -₾7.3m-₾1.7m | ₾1.12bn₾1.02bn |
| Net margin | -144.9%-42.6% | 53.0%53.1% |
| Balance sheet | ||
| Total assets | ₾51.7m₾32.7m | ₾31.77bn₾28.33bn |
| Total equity | -₾10.1m-₾2.8m | ₾4.75bn₾4.27bn |
| ROE | — | 23.6%24.0% |